Drug Database
ES

estrogen (Estratab / esterified estrogen / Menest)

✓ Approved

AbbVie, Inc. · ESR1

什么是 estrogen?

estrogen 是一种治疗药物,由AbbVie, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Estratab, esterified estrogen, Menest
公司AbbVie, Inc.
分子靶点ESR1
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

estrogen 作用于 1 个分子靶点:

ESR1estrogen receptor 1 (ER, ESR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

estrogen 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresHormone replacement therapy✓ Approved

相关研究文献

PubMedNPJ breast cancer2026-11-19

Adaptive immune microenvironment associated with prolonged disease-free interval in estrogen receptor positive breast cancer.

Wang Qichen Q, Sheahan Timothy Patrick TP, Van Alsten Sarah C SC, Cozzo Alyssa Joy AJ et al.

Adaptive immune response is associated with improved breast cancer outcomes, especially in the early interval after estrogen receptor negative (ER-) diagnoses. Long-term outcomes have seldom been evaluated. We characterized immune patterns based on predefined 48 immune genes, including adaptive and innate immune pathways, among 1899 Carolina Breast Cancer Study (CBCS) participants with long-term disease-free interval (DFI) data (with 10+ years follow-up). Latent Class Analysis, modeling both expression patterns and magnitude, identified Adaptive, Innate, and Quiet immune microenvironments. Cox proportional hazards estimated associations between immune classes and DFI in early (≤5 years) and late windows (5-10 years). Quiet immune class was significantly associated with a higher hazard of breast cancer recurrence in ER+ in both 5-year [Hazard Ratio (HR): 2.03, 95% Confidence Interval (CI): (1.16, 3.56)] and 5-to-10-year [HR: 4.93, 95% CI: (1.76, 13.77)] timeframes compared to Adaptive class. Quiet showed a similar but higher association in ER- tumors compared to Adaptive [5-year HR: 2.67 95% CI: (1.65, 4.33)]. In SCAN-B, long-term prognostic associations among ER+ breast cancers were directionally consistent with those observed in the CBCS, although effect sizes were attenuated. Classification of breast cancer microenvironments may have value for predicting long-term breast cancer prognosis.

PMID 43052316
阅读全文 →
PubMedBiology of sex differences2026-11-19

Mapping the sex-dimorphic hormonal ecosystem in osteoarthritis: non-linear interactions between androgen activity and estrogen.

Deng Bin B, Chen Ting T, Chen Qiao Q, Huang Liangzhi L et al.

The pronounced sex disparity in osteoarthritis (OA) risk implicates sex hormones, yet single-hormone studies have yielded inconsistent results. We hypothesized that androgen activity influences OA not in isolation but within a dynamic network defined by sex, menopausal status, and estradiol. We analyzed 13,848 adults from NHANES (2013-2016, 2021-2023) using an integrated framework combining complex-survey regression, two-way restricted cubic splines, generalized additive models (GAMs), and SHAP-based machine learning to model non-linear interactions across the estradiol-FAI plane. Higher free androgen index (FAI) was significantly associated with lower OA risk only in post-menopausal females (OR = 0.85, 95% CI: 0.74-0.97, P = 0.021); associations in pre-menopausal females (OR = 0.75, P = 0.145) and males (OR = 0.94, P = 0.714) were not statistically significant. Non-linear models revealed distinct regional patterns: a "buffering" pattern in post-menopausal females, where the low-estradiol/low-FAI quadrant exhibited the highest risk (GAM P = 0.002; regional synergy mean = 0.077); a "cross-over" pattern in males (GAM P = 0.042); and a flat surface in pre-menopausal females, serving as a negative control. Candidate boundaries (e.g., estradiol ≈ 2.63, FAI ≈ - 0.54 in post-menopausal females) emerged from SHAP dependence plots as hypothesis-generating indicators requiring formal validation. Machine learning confirmed that standalone predictive contributions of sex hormones were minimal (mean |SHAP| ≤ 0.0135), supporting their role as contextual modulators rather than primary drivers. Sex hormone effects on OA are context-dependent and non-linear, only discernible when examined in combination. The regional risk patterns-particularly the low-low quadrant in post-menopausal females-represent the robust core of our findings and provide a conceptual framework for understanding sex disparities through steroid interaction. Candidate boundaries are hypothesis-generating and await validation.

PMID 43053217
阅读全文 →
PubMedBreast cancer research : BCR2026-11-19

Pathomics-based prediction of natural regulatory T cell infiltration in breast cancer.

Xu Yuanbing Y, Pan Yanming Y, Cui Manlu M, Li Jingtao J et al.

Natural regulatory T cells (nTregs) are a key immunosuppressive component of the tumor microenvironment (TME), but their assessment typically requires specialized molecular assays. This study aimed to develop and validate a deep learning-based pathomics model to predict nTregs infiltration directly from routine hematoxylin and eosin (H&E)-stained whole slide images (WSI) of breast cancer and evaluate its prognostic significance. Data from 1097 breast cancer patients in The Cancer Genome Atlas (TCGA) were analyzed. A cohort of 928 patients with complete RNA-seq data was used to establish the prognostic value of nTregs (estimated by ImmuneCellAI). A subset of 791 patients with matched high-quality H&E-stained WSI was randomly split into training (n = 633) and validation (n = 158) cohorts. A total of 1488 quantitative pathomic features were extracted. After feature selection via minimum Redundancy Maximum Relevance (mRMR) and Recursive Feature Elimination (RFE), a Gradient Boosting Machine (GBM) classifier was trained to predict high versus low nTregs status, generating a continuous Pathomics Score (PS). The PS was validated against FOXP3 immunohistochemistry (IHC) and evaluated for its association with overall survival (OS). Multi-omics analyses explored the underlying biology of PS-defined groups. High nTregs infiltration was an independent predictor of poor OS (HR = 1.58, 95% CI 1.10-2.28, p = 0.013). The GBM model achieved an area under the receiver operating characteristic curve (AUC-ROC) of 0.81 (95% CI 0.78-0.85) in the training cohort and 0.72 (95% CI 0.63-0.80) in the validation cohort. The PS showed a strong correlation with FOXP3+ cell density (p < 0.001) and was independently associated with worse OS (HR = 1.68, 95% CI 1.15-2.46, p = 0.008). Patients with high PS exhibited a distinct transcriptomic signature enriched for immune activation pathways (e.g., estrogen responses) and upregulated immune checkpoint genes (e.g., CD276, TNFSF4, TNFSF9), alongside an immunosuppressive microenvironment characterized by increased nTregs and M2-like macrophage estimates. We developed and validated a pathomics model that non-invasively predicts nTregs infiltration and patient prognosis from standard H&E images. The PS serves as a novel, accessible digital biomarker that captures the complexity of an inflamed yet immunosuppressive TME and has the potential to augment clinical decision-making, particularly in resource-limited settings.

PMID 43053193
阅读全文 →
PubMedPsychoneuroendocrinology2026-11-18

Efficacy of estrogen therapy for postpartum depression: A systematic review and meta-analysis.

Rech Peterson P, Candido Ana Claudia Rodrigues ACR, Uggioni Maria Laura Rodrigues MLR, Ferraz Sarah Dagostin SD et al.

Postpartum depression (PPD) is one of the most prevalent mental health complications of the perinatal period and is associated with maternal impairment, disruption of the mother-infant bond, and adverse effects on child cognitive and emotional development. The most widely accepted pathophysiological hypothesis involves the abrupt decline in estrogen concentrations following childbirth, leading to interest in estrogen replacement as a potential therapeutic strategy for PPD. This systematic review and meta-analysis was conducted in accordance with PRISMA 2020 guidelines. Searches were performed in MEDLINE/PubMed, Embase, Cochrane CENTRAL and Scopus using the terms "postpartum depression," "estrogen," "estrogen replacement therapy," and related synonyms. Randomized controlled trials (RCTs) comparing estrogen with placebo for PPD treatment were included. Four RCTs involving 154 women with PPD met the eligibility criteria. The pooled analysis showed a standardized mean difference (SMD) of -0.16 (95% confidence interval (CI) -0.58-0.25; I² = 35%), favoring estrogen but without a statistically significant effect. The certainty of evidence was rated as low according to the GRADE approach, with a two-level downgrade for very serious imprecision due to the limited sample size and wide confidence interval encompassing potentially clinically important benefit, little or no effect, and possible harm. Although estrogen therapy has a biological rationale for PPD treatment, the currently available evidence is insufficient to support its routine clinical use. Further well-designed RCTs with larger sample sizes, standardized methodologies, and adequate pharmacokinetic monitoring are required to clarify the efficacy and safety of estrogen therapy in this population.

PMID 43050794
阅读全文 →
PubMedSAGE open medical case reports2026-11-18

The clinical utility of FES-PET with multiple malignancies: A case report of advanced melanoma and breast cancer.

McLaughlin Shannon S, Medford Arielle J AJ, Kim Janice J, Spring Laura L et al.

Differentiating the primary etiology of metastatic lesions in patients with multiple malignancies can create challenges when it is not feasible to perform a biopsy. We present a case of a 62-year-old patient with metastatic estrogen receptor (ER)+/progesterone receptor (PR)+/human epidermal growth factor 2 amplified breast cancer, metastatic melanoma, and chronic lymphocytic leukemia who developed new pulmonary nodules not amenable to biopsy. Classic fluorodeoxyglucose positron emission tomography (PET) computed tomography (CT) imaging revealed metabolically active pulmonary lesions, but was unable to distinguish which primary cancer was responsible for the metastatic lesion. Subsequent PET/CT using 16α-[18F]-fluoro-17β-estradiol ([18F]FES) radioactive tracer, which binds to estrogen receptors, revealed tracer uptake within the pulmonary nodules, supporting that the new nodules were of breast primary, rather than melanoma. This non-invasive imaging was able to provide diagnostic clarity and directly inform management, leading to a change in systemic therapy. This case highlights the value of FES-PET/CT in characterizing ER-positive disease and distinguishing between competing malignancies when tissue biopsy is not feasible.

PMID 43048512
阅读全文 →
PubMedAnais da Academia Brasileira de Ciencias2026-11-18

Pubertal exposure to glyphosate-based herbicide induces sex-specific endocrine and hepatic lipid alterations in adulthood.

Ribeiro Rosane Aparecida RA, Teleken Jakeline Liara JL, Atella Georgia C GC, Kluck George Eduardo Gabriel GEG et al.

Glyphosate-based herbicides (GBHs) are widely used in agriculture, raising concerns about neuroendocrine and metabolic disruption, particularly during critical developmental windows. This study evaluated the effects of pubertal GBH exposure on biometric, metabolic, hepatic, and endocrine parameters in adult female and male mice. From postnatal weeks 4 to 8, C57Bl/6 mice received daily oral gavage with distilled water [control (CTL)] or 50 mg/kg body weight (BW) of GBH. At 21 weeks, biometric, biochemical, and hormonal parameters were analyzed. BW, Lee index, and abdominal fat were not affected by GBH exposure in either sex. Similarly, glycemia, lipidemia, insulinemia, glucose tolerance, and insulin sensitivity did not differ between groups. However, GBH exposure induced sex-specific changes in hepatic cholesterol: GBH females exhibited reduced esterified cholesterol (e-CHOL), whereas males showed increased e-CHOL and free CHOL. No significant hormonal changes were observed in GBH-exposed females. In contrast, males exhibited decreased follicle-stimulating hormone levels and increased testosterone and thyroid-stimulating hormone concentrations in adulthood. These results suggest that pubertal exposure to GBH, even at a dose considered safe by regulatory agencies, can induce long-lasting, sex-specific alterations in hepatic lipid metabolism and endocrine function, reinforcing concerns about GBHs as potential endocrine and metabolic disruptors.

PMID 43048952
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多estrogen